Prognostic factors and their importance in relapsed and refractory AML: Comments on "Additional impact of mutational genotype on prognostic determination in resistant and relapsed acute myeloid leukaemia" by Linch et al
Leuk Res. 2021 Jun:105:106572.
doi: 10.1016/j.leukres.2021.106572.
Epub 2021 Mar 30.
1 Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia; Department of Haematology, PathWest Laboratory Medicine, Perth, Australia.
2 Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia; Department of Haematology, PathWest Laboratory Medicine, Perth, Australia; School of Biomedical Sciences, University of Western Australia, Perth, Australia. Electronic address: carolyn.grove@health.wa.gov.au.